Clinical efficacy and safety of aflibercept biosimilars in neovascular age-related macular degeneration: a systematic review and meta-analysis of randomised controlled trials.

Saved in:
Bibliographic Details
Title: Clinical efficacy and safety of aflibercept biosimilars in neovascular age-related macular degeneration: a systematic review and meta-analysis of randomised controlled trials.
Authors: Zhang C; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA cfhzhang@gmail.com., Sonik NR; Miller School of Medicine, University of Miami, Miami, Florida, USA., Ayoubi M; Miller School of Medicine, University of Miami, Miami, Florida, USA., AbouKasm G; Miller School of Medicine, University of Miami, Miami, Florida, USA., Zhu D; Northwell Health Eye Institute, Great Heck, New York, USA.; Department of Ophthalmology, Manhattan Eye Ear and Throat Hospital, New York, NY, USA., Fan JC; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA., Albini TA; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA., Yannuzzi NA; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.
Source: The British journal of ophthalmology [Br J Ophthalmol] 2026 Jun 03. Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2079 (Electronic) Linking ISSN: 00071161 NLM ISO Abbreviation: Br J Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2079
DOI:10.1136/bjo-2025-328196